Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3
T Ohteki, M Parsons, A Zakarian, R G Jones, L T Nguyen, J R Woodgett, P S Ohashi, T Ohteki, M Parsons, A Zakarian, R G Jones, L T Nguyen, J R Woodgett, P S Ohashi
Abstract
Glycogen synthase kinase (GSK)-3 is a protein serine/threonine kinase that regulates differentiation and cell fate in a variety of organisms. This study examined the role of GSK-3 in antigen-specific T cell responses. Using resting T cells from P14 T cell receptor (TCR)-transgenic mice (specific for the lymphocytic choriomeningitis virus and H-2D(b)), we demonstrated that GSK-3beta was inactivated by serine phosphorylation after viral peptide-specific stimulation in vitro. To further investigate the role of GSK-3, we have generated a retroviral vector that expresses a constitutively active form of GSK-3beta that has an alanine substitution at the regulatory amino acid, serine 9 (GSK-3betaA9). Retroviral transduction of P14 TCR-transgenic bone marrow stem cells, followed by reconstitution, led to the expression of GSK-3betaA9 in bone marrow chimeric mice. T cells from chimeric mice demonstrate a reduction in proliferation and interleukin (IL)-2 production. In contrast, in vitro assays done in the presence of the GSK-3 inhibitor lithium led to dramatically prolonged T cell proliferation and increased IL-2 production. Furthermore, in the presence of lithium, we show that nuclear factor of activated T cells (NF-AT)c remains in the nucleus after antigen-specific stimulation of T cells. Together, these data demonstrate that GSK-3 negatively regulates the duration of T cell responses.
Figures
References
- Qian D., Weiss A. T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 1997;9:205–212.
- Alberola-Ila J., Takaki S., Kerner J.D., Perlmutter R.M. Differential signalling by lymphocyte antigen receptors. Annu. Rev. Immunol. 1997;15:125–154.
- Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT familyregulation and function. Annu. Rev. Immunol. 1997;15:707–747.
- Woodgett J.R. Regulation and functions of the glycogen synthase kinase-3 subfamily. Cancer Biol. 1994;5:269–275.
- Welsh G.I., Wilson C., Proud C.G. GSK3a SHAGGY frog story. Cell Biol. 1996;6:274–279.
- Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 β by phosphorylationnew kinase connections in insulin and growth-factor signalling. Biochem. J. 1993;296:15–19.
- Stambolic V., Woodgett J.R. Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem. J. 1994;303:701–704.
- Cook D., Fry M.J., Hughes K., Sumathipala R., Woodgett J.R., Dale T.C. Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO (Eur. Mol. Biol. Organ.) J. 1996;15:4526–4536.
- Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells. Curr. Biol. 1996;6:1664–1668.
- Moon R.T., Brown J.D., Yang-Snyder J.A., Miller J.R. Structurally related receptors and antagonists compete for secreted Wnt ligands. Cell. 1997;88:725–728.
- Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 1997;275:1930–1933.
- Welsh G.I., Miyamoto S., Price N.T., Safer B., Proud C.G. T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3. J. Biol. Chem. 1996;271:11410–11413.
- Pircher H., Bürki K., Lang R., Hengartner H., Zinkernagel R. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989;342:559–561.
- Hawley R.G., Lieu F.H.L., Fong A.Z.C., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994;1:136–138.
- Ally B.A., Hawley T.S., MacKall-Faienza K., Kündig T.M., Oehen S.U., Pircher H., Hawley R.G., Ohashi P.S. Prevention of autoimmune disease by retroviral-mediated gene therapy. J. Immunol. 1995;155:5404–5408.
- Sebzda E., Kündig T.M., Thomson C.T., Aoki K., Mak S.Y., Mayer J., Zamborelli T.M., Nathenson S., Ohashi P.S. Mature T cell reactivity altered by a peptide agonist that induces positive selection. J. Exp. Med. 1996;183:1093–1104.
- Mariathasan S., Bachmann M.F., Bouchard D., Ohteki T., Ohashi P.S. Degree of TCR internalization and Ca2+ flux correlates with thymocyte selection. J. Immunol. 1998;161:6030–6037.
- Brownlees J., Irving N.G., Brion J.-P., Gibb B.J., Wagner U., Woodgett J., Miller C.C. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes. Neuroreport. 1997;8:3251–3255.
- Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA. 1996;93:8455–8459.
- Hedgepeth C.M., Conrad L.J., Zhang J., Huang H.C., Lee V.M., Klein P.S. Activation of the Wnt signaling pathwaya molecular mechanism for lithium action. Dev. Biol. 1997;185:82–91.
- Kehlenbach R.H., Dickmanns A., Gerace L. Nucleocytoplasmic shuttling factors including Ran and CRM1 mediate nuclear export of NFAT in vitro. J. Cell Biol. 1998;141:863–874.
- Zhu J., McKeon F. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature. 1999;398:256–260.
- Beals C.R., Clipstone N.A., Ho S.N., Crabtree G.R. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev. 1997;11:824–834.
- Astoul E., Watton S., Cantrell D. The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 1999;145:1511–1520.
- Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996;14:233–258.
- Tarakhovsky A., Kanner S.B., Hombach J., Ledbetter J.A., Müller W., Killeen N., Rajewsky K. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 1995;269:535–537.
- Azzam H.S., Grinberg A., Lui K., Shen H., Shores E.W., Love P.E. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 1998;188:2301–2311.
- Schmedt C., Saijo K., Niidome T., Kühn R., Aizawa S., Tarakhovsky A. Csk controls antigen receptor-mediated development and selection of T-lineage cells. Nature. 1998;394:901–904.
- Plas D.R., Johnson R., Pingel J.T., Matthews R.J., Dalton M., Roy G., Chan A.C., Thomas M.L. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 1996;272:1173–1176.
- Pani G., Fischer K.-D., Mlinaric-Rascan I., Siminovitch K.A. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 1996;184:839–852.
- Lorenz U., Ravichandran K.S., Burakoff S.J., Neel B.G. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc. Natl. Acad. Sci. USA. 1996;93:9624–9629.
- Carter J.D., Neel B.G., Lorenz U. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int. Immunol. 1999;11:1999–2014.
- Sun L., Youn H.D., Loh C., Stolow M., He W., Liu J.O. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity. 1998;8:703–711.
- Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B.F., Langdon W.Y., Bowtell D.D.L. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell. Biol. 1998;18:4872–4882.
- Naramura M., Kole H.K., Hu R.-J., Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA. 1998;95:15447–15552.
Source: PubMed